Littlejohn & Co’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-218,193
Closed -$29M 27
2024
Q2
$29M Sell
218,193
-32,600
-13% -$3.92M 14.79% 3
2024
Q1
$26.4M Hold
250,793
16.89% 2
2023
Q4
$19M Buy
250,793
+42,749
+21% +$2.71M 13.25% 3
2023
Q3
$13.7M Hold
208,044
11.65% 2
2023
Q2
$16.9M Sell
208,044
-24,651
-11% -$1.75M 11.79% 2
2023
Q1
$13.8M Hold
232,695
8.27% 5
2022
Q4
$11.4M Hold
232,695
6.79% 4
2022
Q3
$12M Sell
232,695
-25,000
-10% -$1.48M 6.24% 4
2022
Q2
$13.5M Buy
257,695
+77,963
+43% +$5.43M 4.9% 4
2022
Q1
$15.4M Buy
179,732
+936
+0.5% +$76.9K 4.05% 5
2021
Q4
$14.6M Buy
+178,796
New +$13.1M 3.8% 8

Other funds holding THC

Littlejohn & Co's THC Position: Q3 2024 in Review

Littlejohn & Co sold out of Tenet Healthcare (THC) in Q3 2024, closing a stake of 218,193 shares — an estimated $29M sold.

Littlejohn & Co first reported a position in THC in Q4 2021 and held it in 11 quarters. The position peaked at $29M in Q2 2024. 602 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • Littlejohn & Co reported no remaining Tenet Healthcare position as of Q3 2024 after selling out during the quarter.
  • Littlejohn & Co sold 218,193 Tenet Healthcare shares in Q3 2024, an estimated $29M.
  • Littlejohn & Co first reported a position in Tenet Healthcare in Q4 2021 and held it in 11 quarters.
  • Littlejohn & Co's Tenet Healthcare position peaked at $29M in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on Littlejohn & Co's 13F filing for Q3 2024, filed 13 Nov 2024.